Scientists have assembled a library of immune receptors that direct T cells to target cells with mutations in p53, the most commonly mutated gene in human cancers.
July 2022. Full story at National Cancer Institute.
Scientists have assembled a library of immune receptors that direct T cells to target cells with mutations in p53, the most commonly mutated gene in human cancers.
July 2022. Full story at National Cancer Institute.